Table 1.

Clinical Trials In Progress—FMT In NAFLD.

	Title	Status	Interventions
1	Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease	Unknown status	Other: intestinal microbiota transplantation
2	The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)	Unknown status	Other: Gut microbiome transplantation
3	Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis (NASH). A Pilot Study	Unknown status	Drug: Fecal Microbiota Transplantation
4	Fecal Microbiota Transplantation for the Treatment of Non- Alcoholic Steatohepatitis	Not yet recruiting	Other: Fecal Microbiota Transplantation
5	Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver Disease	Unknown status	• Dietary Supplement: Diet • Other: FMT • Other: Physical Activity
6	Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD	Completed	• Biological: Autologous • Biological: Allogeneic
7	A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease	Not yet recruiting	• Drug: PRIM-DJ2727 • Drug: Placebo
8	Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis	Not yet recruiting	• Drug: Group 1 or Experimental group • Other: Group 2 or Control group
9	Synbiotics and Fecal Microbiota Transplantation to Treat Non- Alcoholic Steatohepatitis	Recruiting	Combination Product: LFMT-capsules
10	Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD—the DIFTOB Study	Active, not recruiting	Other: FMT and placebo
11	Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.	Unknown status	• Biological: Fecal Microbiota Transplant • Other: Standard Medical Treatment